Document is current

Any future updates will be listed below

Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial

Crossref DOI link: https://doi.org/10.1186/s12936-016-1145-5

Published Online: 2016-02-18

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark